Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 25, 2023 Filed Jul 27, 2023 14:39 UTC |
Hinrichs Joseph RDirector
|
GrantRestricted Stock Units · Derivative | 7,321 | $15.49 | $113,402.29 |
DisclosureSEC source: 0001209191-23-043468 · doc4.xml · derivative · entry 1 Hinrichs Joseph R · CIK 0001422651 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,321 Underlying: Common Stock · 7,321 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| July 03, 2023 Filed Jul 5, 2023 19:54 UTC |
Mahendra-Rajah PrashanthDirector
|
GrantRestricted Stock Units · Derivative | 592 | $13.72 | $8,122.24 |
DisclosureSEC source: 0001209191-23-040927 · doc4.xml · derivative · entry 1 Mahendra-Rajah Prashanth · CIK 0001609983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,593 Underlying: Common Stock · 592 shares Expires not disclosed F1 · security: RSUs accrued, pursuant to an election by the reporting person, to the Retainer Deferral Account of the reporting person in accordance with the Company's Outside Directors' Equity Participation Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Retainer Deferral Account of the reporting person as of the date of this statement. Read SEC document |
| July 03, 2023 Filed Jul 5, 2023 19:53 UTC |
CLAYTON NORMADirector
|
GrantRestricted Stock Units · Derivative | 1,184 | $13.72 | $16,244.48 |
DisclosureSEC source: 0001209191-23-040925 · doc4.xml · derivative · entry 1 CLAYTON NORMA · CIK 0001877468 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,267 Underlying: Common Stock · 1,184 shares Expires not disclosed F1 · security: RSUs accrued, pursuant to an election by the reporting person, to the Retainer Deferral Account of the reporting person in accordance with the Company's Outside Directors' Equity Participation Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Retainer Deferral Account of the reporting person as of the date of this statement. Read SEC document |
| May 05, 2023 Filed May 9, 2023 20:09 UTC |
Zamarro Christina LEVP & Chief Financial Officer
|
Exercise / conversion2017 Plan Restricted Stock Units · Derivative | 16,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028238 · doc4.xml · derivative · entry 4 Zamarro Christina L · CIK 0001934429 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,612 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted May 5, 2020. F3 · derivative.exercise_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted May 5, 2020. F3 · derivative.expiration_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted May 5, 2020. Read SEC document |
| May 05, 2023 Filed May 9, 2023 20:09 UTC |
Zamarro Christina LEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 5,042 | $11.43 | $57,630.06 |
DisclosureSEC source: 0001209191-23-028238 · doc4.xml · nonDerivative · entry 2 Zamarro Christina L · CIK 0001934429 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,272 F1 · kind: Shares of common stock withheld by the issuer for the payment of withholding taxes. Read SEC document |
| May 05, 2023 Filed May 9, 2023 20:09 UTC |
Zamarro Christina LEVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 16,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028238 · doc4.xml · nonDerivative · entry 1 Zamarro Christina L · CIK 0001934429 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:38 UTC |
Williams ThomasDirector
|
GrantRestricted Stock Units · Derivative | 15,139 | $10.83 | $163,955.37 |
DisclosureSEC source: 0001209191-23-024099 · doc4.xml · derivative · entry 1 Williams Thomas L · CIK 0001320730 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,750 Underlying: Common Stock · 15,139 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:36 UTC |
Wessel MichaelDirector
|
GrantRestricted Stock Units · Derivative | 15,139 | $10.83 | $163,955.37 |
DisclosureSEC source: 0001209191-23-024096 · doc4.xml · derivative · entry 1 Wessel Michael · CIK 0001346244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,492 Underlying: Common Stock · 15,139 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:35 UTC |
PALMORE RODERICK ADirector
|
GrantRestricted Stock Units · Derivative | 15,139 | $10.83 | $163,955.37 |
DisclosureSEC source: 0001209191-23-024095 · doc4.xml · derivative · entry 1 PALMORE RODERICK A · CIK 0001218964 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,443 Underlying: Common Stock · 15,139 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:32 UTC |
MCGLADE JOHN EDirector
|
GrantRestricted Stock Units · Derivative | 15,139 | $10.83 | $163,955.37 |
DisclosureSEC source: 0001209191-23-024094 · doc4.xml · derivative · entry 1 MCGLADE JOHN E · CIK 0001265896 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,211 Underlying: Common Stock · 15,139 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:30 UTC |
Mahendra-Rajah PrashanthDirector
|
GrantRestricted Stock Units · Derivative | 15,139 | $10.83 | $163,955.37 |
DisclosureSEC source: 0001209191-23-024093 · doc4.xml · derivative · entry 1 Mahendra-Rajah Prashanth · CIK 0001609983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,244 Underlying: Common Stock · 15,139 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:29 UTC |
Lewis Karla RDirector
|
GrantRestricted Stock Units · Derivative | 15,139 | $10.83 | $163,955.37 |
DisclosureSEC source: 0001209191-23-024092 · doc4.xml · derivative · entry 1 Lewis Karla R · CIK 0001256541 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,616 Underlying: Common Stock · 15,139 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:25 UTC |
KOELLNER LAURETTE TDirector
|
GrantRestricted Stock Units · Derivative | 15,139 | $10.83 | $163,955.37 |
DisclosureSEC source: 0001209191-23-024091 · doc4.xml · derivative · entry 1 KOELLNER LAURETTE T · CIK 0001182054 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,505 Underlying: Common Stock · 15,139 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:24 UTC |
Siu Hera KDirector
|
GrantRestricted Stock Units · Derivative | 15,139 | $10.83 | $163,955.37 |
DisclosureSEC source: 0001209191-23-024089 · doc4.xml · derivative · entry 1 Siu Hera K · CIK 0001796462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,198 Underlying: Common Stock · 15,139 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:22 UTC |
Geissler WernerDirector
|
GrantRestricted Stock Units · Derivative | 15,139 | $10.83 | $163,955.37 |
DisclosureSEC source: 0001209191-23-024083 · doc4.xml · derivative · entry 1 Geissler Werner · CIK 0001402226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,402 Underlying: Common Stock · 15,139 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:19 UTC |
FIRESTONE JAMES ADirector
|
GrantRestricted Stock Units · Derivative | 15,139 | $10.83 | $163,955.37 |
DisclosureSEC source: 0001209191-23-024077 · doc4.xml · derivative · entry 1 FIRESTONE JAMES A · CIK 0001207838 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,492 Underlying: Common Stock · 15,139 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:17 UTC |
CLAYTON NORMADirector
|
GrantRestricted Stock Units · Derivative | 15,139 | $10.83 | $163,955.37 |
DisclosureSEC source: 0001209191-23-024075 · doc4.xml · derivative · entry 1 CLAYTON NORMA · CIK 0001877468 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,253 Underlying: Common Stock · 15,139 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:02 UTC |
Williams ThomasDirector
|
GrantRestricted Stock Units · Derivative | 3,663 | $10.92 | $39,999.96 |
DisclosureSEC source: 0001209191-23-023250 · doc4.xml · derivative · entry 1 Williams Thomas L · CIK 0001320730 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,611 Underlying: Common Stock · 3,663 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:00 UTC |
Wessel MichaelDirector
|
GrantRestricted Stock Units · Derivative | 3,663 | $10.92 | $39,999.96 |
DisclosureSEC source: 0001209191-23-023246 · doc4.xml · derivative · entry 1 Wessel Michael · CIK 0001346244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,353 Underlying: Common Stock · 3,663 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 19:58 UTC |
Siu Hera KDirector
|
GrantRestricted Stock Units · Derivative | 3,663 | $10.92 | $39,999.96 |
DisclosureSEC source: 0001209191-23-023245 · doc4.xml · derivative · entry 1 Siu Hera K · CIK 0001796462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,059 Underlying: Common Stock · 3,663 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 19:54 UTC |
MCGLADE JOHN EDirector
|
GrantRestricted Stock Units · Derivative | 3,663 | $10.92 | $39,999.96 |
DisclosureSEC source: 0001209191-23-023243 · doc4.xml · derivative · entry 1 MCGLADE JOHN E · CIK 0001265896 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,072 Underlying: Common Stock · 3,663 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 19:56 UTC |
PALMORE RODERICK ADirector
|
GrantRestricted Stock Units · Derivative | 3,663 | $10.92 | $39,999.96 |
DisclosureSEC source: 0001209191-23-023244 · doc4.xml · derivative · entry 1 PALMORE RODERICK A · CIK 0001218964 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,304 Underlying: Common Stock · 3,663 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 19:53 UTC |
Mahendra-Rajah PrashanthDirector
|
GrantRestricted Stock Units · Derivative | 744 | $10.92 | $8,124.48 |
DisclosureSEC source: 0001209191-23-023242 · doc4.xml · derivative · entry 2 Mahendra-Rajah Prashanth · CIK 0001609983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,001 Underlying: Common Stock · 744 shares Expires not disclosed F4 · security: RSUs accrued, pursuant to an election by the reporting person, to the Retainer Deferral Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F5 · balance_after: Total RSUs accrued to the Retainer Deferral Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 19:53 UTC |
Mahendra-Rajah PrashanthDirector
|
GrantRestricted Stock Units · Derivative | 3,663 | $10.92 | $39,999.96 |
DisclosureSEC source: 0001209191-23-023242 · doc4.xml · derivative · entry 1 Mahendra-Rajah Prashanth · CIK 0001609983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,105 Underlying: Common Stock · 3,663 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 19:51 UTC |
Lewis Karla RDirector
|
GrantRestricted Stock Units · Derivative | 3,663 | $10.92 | $39,999.96 |
DisclosureSEC source: 0001209191-23-023239 · doc4.xml · derivative · entry 1 Lewis Karla R · CIK 0001256541 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,477 Underlying: Common Stock · 3,663 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 19:49 UTC |
KOELLNER LAURETTE TDirector
|
GrantRestricted Stock Units · Derivative | 3,663 | $10.92 | $39,999.96 |
DisclosureSEC source: 0001209191-23-023238 · doc4.xml · derivative · entry 1 KOELLNER LAURETTE T · CIK 0001182054 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,365 Underlying: Common Stock · 3,663 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 19:47 UTC |
Geissler WernerDirector
|
GrantRestricted Stock Units · Derivative | 3,663 | $10.92 | $39,999.96 |
DisclosureSEC source: 0001209191-23-023237 · doc4.xml · derivative · entry 1 Geissler Werner · CIK 0001402226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,263 Underlying: Common Stock · 3,663 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 19:45 UTC |
FIRESTONE JAMES ADirector
|
GrantRestricted Stock Units · Derivative | 3,663 | $10.92 | $39,999.96 |
DisclosureSEC source: 0001209191-23-023236 · doc4.xml · derivative · entry 1 FIRESTONE JAMES A · CIK 0001207838 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,353 Underlying: Common Stock · 3,663 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 19:44 UTC |
CLAYTON NORMADirector
|
GrantRestricted Stock Units · Derivative | 1,488 | $10.92 | $16,248.96 |
DisclosureSEC source: 0001209191-23-023235 · doc4.xml · derivative · entry 2 CLAYTON NORMA · CIK 0001877468 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,083 Underlying: Common Stock · 1,488 shares Expires not disclosed F4 · security: RSUs accrued, pursuant to an election by the reporting person, to the Retainer Deferral Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F5 · balance_after: Total RSUs accrued to the Retainer Deferral Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 19:44 UTC |
CLAYTON NORMADirector
|
GrantRestricted Stock Units · Derivative | 3,663 | $10.92 | $39,999.96 |
DisclosureSEC source: 0001209191-23-023235 · doc4.xml · derivative · entry 1 CLAYTON NORMA · CIK 0001877468 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,114 Underlying: Common Stock · 3,663 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 14:33 UTC |
Snyder Margaret VVice President and Controller
|
Grant2022 Plan Restricted Stock Units · Derivative | 6,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-022502 · doc4.xml · derivative · entry 2 Snyder Margaret V · CIK 0001971622 · Vice President and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,805 Underlying: Common Stock · 6,805 shares Expires not disclosed F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on March 31, 2026. F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on March 31, 2026. F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on March 31, 2026. F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on March 31, 2026. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 14:33 UTC |
Snyder Margaret VVice President and Controller
|
Grant2022 Plan Performance Share Units · Derivative | 4,537 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-022502 · doc4.xml · derivative · entry 1 Snyder Margaret V · CIK 0001971622 · Vice President and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,537 Underlying: Common Stock · 4,537 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:52 UTC |
Zamarro Christina LEVP & Chief Financial Officer
|
Grant2022 Plan Restricted Stock Units · Derivative | 59,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014172 · doc4.xml · derivative · entry 2 Zamarro Christina L · CIK 0001934429 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,158 Underlying: Common Stock · 59,158 shares Expires not disclosed F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:52 UTC |
Zamarro Christina LEVP & Chief Financial Officer
|
Grant2022 Plan Performance Units · Derivative | 39,439 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014172 · doc4.xml · derivative · entry 1 Zamarro Christina L · CIK 0001934429 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,439 Underlying: Common Stock · 39,439 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:51 UTC |
WELLS DARREN REVP & Chief Admin. Officer
|
Grant2022 Plan Restricted Stock Units · Derivative | 84,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014164 · doc4.xml · derivative · entry 2 WELLS DARREN R · CIK 0001190977 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,136 Underlying: Common Stock · 84,136 shares Expires not disclosed F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:51 UTC |
WELLS DARREN REVP & Chief Admin. Officer
|
Grant2022 Plan Performance Share Units · Derivative | 56,091 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014164 · doc4.xml · derivative · entry 1 WELLS DARREN R · CIK 0001190977 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,091 Underlying: Common Stock · 56,091 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:49 UTC |
VanderLind GarySR VP & Chief Human Res. Ofcr.
|
Grant2022 Plan Restricted Stock Units · Derivative | 34,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014159 · doc4.xml · derivative · entry 2 VanderLind Gary · CIK 0001765321 · SR VP & Chief Human Res. Ofcr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,180 Underlying: Common Stock · 34,180 shares Expires not disclosed F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:49 UTC |
VanderLind GarySR VP & Chief Human Res. Ofcr.
|
Grant2022 Plan Performance Units · Derivative | 22,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014159 · doc4.xml · derivative · entry 1 VanderLind Gary · CIK 0001765321 · SR VP & Chief Human Res. Ofcr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,787 Underlying: Common Stock · 22,787 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:47 UTC |
Scocos Evan MVice President and Controller
|
Grant2022 Plan Restricted Stock Units · Derivative | 13,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014156 · doc4.xml · derivative · entry 2 Scocos Evan M · CIK 0001674989 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,146 Underlying: Common Stock · 13,146 shares Expires not disclosed F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:47 UTC |
Scocos Evan MVice President and Controller
|
Grant2022 Plan Performance Units · Derivative | 8,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014156 · doc4.xml · derivative · entry 1 Scocos Evan M · CIK 0001674989 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,764 Underlying: Common Stock · 8,764 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:46 UTC |
Phillips David EmmittSr VP and General Counsel
|
Grant2022 Plan Restricted Stock Units · Derivative | 39,439 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014153 · doc4.xml · derivative · entry 2 Phillips David Emmitt · CIK 0001777552 · Sr VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,439 Underlying: Common Stock · 39,439 shares Expires not disclosed F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:46 UTC |
Phillips David EmmittSr VP and General Counsel
|
Grant2022 Plan Performance Units · Derivative | 26,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014153 · doc4.xml · derivative · entry 1 Phillips David Emmitt · CIK 0001777552 · Sr VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,292 Underlying: Common Stock · 26,292 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:43 UTC |
McClellan Stephen RPresident, Americas
|
Grant2022 Plan Restricted Stock Units · Derivative | 76,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014150 · doc4.xml · derivative · entry 2 McClellan Stephen R · CIK 0001447779 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,248 Underlying: Common Stock · 76,248 shares Expires not disclosed F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:43 UTC |
McClellan Stephen RPresident, Americas
|
Grant2022 Plan Performance Units · Derivative | 50,832 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014150 · doc4.xml · derivative · entry 1 McClellan Stephen R · CIK 0001447779 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,832 Underlying: Common Stock · 50,832 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:41 UTC |
Madarang NathanielPresident, Asia Pacific
|
Grant2022 Plan Restricted Stock Units · Derivative | 28,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014146 · doc4.xml · derivative · entry 2 Madarang Nathaniel · CIK 0001850599 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,921 Underlying: Common Stock · 28,921 shares Expires not disclosed F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:41 UTC |
Madarang NathanielPresident, Asia Pacific
|
Grant2022 Plan Performance Units · Derivative | 19,281 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014146 · doc4.xml · derivative · entry 1 Madarang Nathaniel · CIK 0001850599 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,281 Underlying: Common Stock · 19,281 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:39 UTC |
KRAMER RICHARD JDirector · Chairman of the Bd, CEO & Pres
|
Grant2022 Plan Restricted Stock Units · Derivative | 280,017 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014142 · doc4.xml · derivative · entry 2 KRAMER RICHARD J · CIK 0001201067 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,017 Underlying: Common Stock · 280,017 shares Expires not disclosed F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:39 UTC |
KRAMER RICHARD JDirector · Chairman of the Bd, CEO & Pres
|
Grant2022 Plan Performance Units · Derivative | 186,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014142 · doc4.xml · derivative · entry 1 KRAMER RICHARD J · CIK 0001201067 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,678 Underlying: Common Stock · 186,678 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:38 UTC |
Helsel Christopher PSr VP Glbl Ops Chief Tech Ofcr
|
Grant2022 Plan Restricted Stock Units · Derivative | 37,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014139 · doc4.xml · derivative · entry 2 Helsel Christopher P · CIK 0001763728 · Sr VP Glbl Ops Chief Tech Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,467 Underlying: Common Stock · 37,467 shares Expires not disclosed F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:38 UTC |
Helsel Christopher PSr VP Glbl Ops Chief Tech Ofcr
|
Grant2022 Plan Performance Units · Derivative | 24,978 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014139 · doc4.xml · derivative · entry 1 Helsel Christopher P · CIK 0001763728 · Sr VP Glbl Ops Chief Tech Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,978 Underlying: Common Stock · 24,978 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.